Published in Haemostasis on January 01, 1974
Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest (1977) 3.14
Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. J Clin Pathol (1983) 1.06
Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets. J Clin Pathol (1982) 0.82
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ (1998) 6.07
Travel and risk of venous thrombosis. Lancet (2000) 5.23
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med (1996) 4.10
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med (2003) 3.94
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med (1998) 2.03
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
Synovectomy, a new approach to haemophilic arthropathy. Acta Haematol (1969) 1.64
A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med (1996) 1.45
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica (1999) 1.38
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24
Decreased fluid volume to reduce organ damage: a new approach to burn shock resuscitation? A preliminary study. Resuscitation (2006) 1.24
The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21
Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res (1996) 1.20
The suppurative abscess of an endometriosic ovarian cyst due to Salmonella brandenburg. Infection (1982) 1.18
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Serum albumin in Hodgkin's disease. Cancer (1985) 1.17
Laparoscopic hernia repair: a prospective comparison of TAPP and IPOM techniques. Surg Laparosc Endosc (1997) 1.17
The effect of surgical drain together with a secondary closure technique on postoperative trismus, swelling and pain after mandibular third molar surgery. Int J Oral Maxillofac Surg (1988) 1.11
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica (2000) 1.08
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer (1990) 1.07
Ovarian cancer and venous thromboembolic risk. Gynecol Oncol (2005) 1.05
Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart (2002) 1.02
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. J Thromb Haemost (2007) 1.01
Primary splenic lymphoma: does it exist? Haematologica (1994) 1.00
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
Lung ultrasound in the ICU: from diagnostic instrument to respiratory monitoring tool. Minerva Anestesiol (2012) 0.99
Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg (2000) 0.98
Morphological characteristics of primary enamel surfaces versus permanent enamel surfaces: SEM digital analysis. Eur J Paediatr Dent (2011) 0.97
Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95
Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer (1983) 0.95
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Can causes of false-normal D-dimer test [SimpliRED] results be identified? Thromb Res (2003) 0.94
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost (2005) 0.94
Hodgkin's disease prognosis: a directly predictive equation. Lancet (1988) 0.93
Enhanced in vitro phagocytic power of macrophages from PPD-stimulated skin sites in human subjects hypersensitive to PPD. Clin Exp Immunol (1973) 0.93
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res (1988) 0.93
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol (2004) 0.93
Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax (2002) 0.92
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol (1989) 0.91
Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens (1993) 0.91
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology (1991) 0.90
Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol (1992) 0.90
A prognostic index for multiple myeloma. Br J Cancer (1996) 0.90
The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica (1999) 0.89
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. Haematologica (1975) 0.89
Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J Thromb Haemost (2009) 0.89
Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes. Cancer (1983) 0.88
Epsilon-aminocaproic acid for synovectomy in haemophilic patients. Acta Haematol (1972) 0.88
[The in vivo phagocytic activity of human macrophages in the tuberculin skin test]. Riv Emoter Immunoematol (1967) 0.88
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia (1993) 0.87
Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in a hematological/oncological outpatient section. Haematologica (1989) 0.87
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica (1997) 0.87
Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura. Clin Exp Rheumatol (1988) 0.87
Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients. Blood (1989) 0.86
Synovectomy in haemophilic arthropathy. A new approach to therapy and haemostasis. Schweiz Med Wochenschr (1970) 0.86
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. Cancer (1991) 0.86
Letter: Impaired leukotaxis in viral hepatitis B. N Engl J Med (1975) 0.86
Synovectomy for haemophilic haemarthrosis. Lancet (1968) 0.86
[Clinical course and incidence of post-thrombophlebitic syndrome after profound asymptomatic deep vein thrombosis. Results of a transverse epidemiologic study]. Minerva Cardioangiol (1997) 0.85
Limulus test in Escherichia coli enteritis. Lancet (1975) 0.85
Improvement of hyperinsulinemic diabetes following removal of a meningioma in Werner's syndrome. A case report. Acta Diabetol Lat (1984) 0.85
Endothelin and nitric oxide synthase in lymphatic endothelial cells: immunolocalization in vivo and in vitro. Anat Rec (1997) 0.85
[Occupational accidents in temporary work]. Med Lav (2001) 0.85
Characterization of procoagulant activity produced by cultures of human monocytes and lymphocytes separated in colloidal silica-polvinylpyrrolidone gradients. Clin Lab Haematol (1980) 0.85
Problems in the detection of carriers of haemophilia A. J Clin Pathol (1975) 0.84
Biological features of the clone involved in primary amyloidosis (AL). Leukemia (2001) 0.84
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension. Anticancer Res (1991) 0.84
Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br J Pharmacol (1996) 0.84
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy. Int J Clin Lab Res (1998) 0.84
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP. Haematologica (1995) 0.84
New clinical criteria for the assessment of liver involvement in Hodgkin's disease. Eur J Cancer Clin Oncol (1982) 0.84
Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut (1989) 0.84
Silymarine during maintenance therapy of acute promyelocytic leukemia. Haematologica (1994) 0.84
Inhibiting effect of non-steroidal anti-inflammatory drugs on the chemotaxis of human leukocytes in vitro. Int J Clin Pharmacol Biopharm (1977) 0.83
[Portal catheterization. Transumbilical porto-manometry and porto-hepatography: physiopathological and clinical remarks]. Presse Med (1966) 0.83
Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol (1979) 0.83
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. Haematologica (2000) 0.83
IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. Nephron (1996) 0.83
Serum cytokine levels after small bowel transplantation in pigs. Transplant Proc (1994) 0.82
Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma. J Clin Pathol (1990) 0.82
Immunological reactivity of serum ferritin in patients with malignancy. Tumori (1985) 0.82
Surgical and chemical synovectomy. Ann N Y Acad Sci (1975) 0.82
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerations. Cancer (1988) 0.82
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol. Eur J Cancer (2003) 0.82